Setting the hemoglobin A1c target in type 2 diabetes: a priori, a posteriori, or neither?

Dario Giugliano; Maria Ida Maiorino; Giuseppe Bellastella; Michela Petrizzo; Antonio Ceriello; Stefano Genovese; Katherine Esposito

doi:10.1007/s12020-015-0549-2

Setting the hemoglobin A1c target in type 2 diabetes: a priori, a posteriori, or neither?

Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, Michela Petrizzo, Antonio Ceriello, Stefano Genovese, Katherine Esposito

IRCCS Multimedica

Research output: Contribution to journal › Article › peer-review

Abstract

Current guidelines specify hemoglobin A1c (HbA1c) targets around or less than 7.0 %, with more (

Original language	English
Pages (from-to)	56-60
Number of pages	5
Journal	Endocrine
Volume	50
Issue number	1
DOIs	https://doi.org/10.1007/s12020-015-0549-2
Publication status	Published - Sep 25 2015

Keywords

A posteriori
A priori
HbA1c target
Type 2 diabetes

ASJC Scopus subject areas

Endocrinology
Endocrinology, Diabetes and Metabolism

Access to Document

10.1007/s12020-015-0549-2

Fingerprint Dive into the research topics of 'Setting the hemoglobin A1c target in type 2 diabetes: a priori, a posteriori, or neither?'. Together they form a unique fingerprint.

Cite this

@article{36e499abf581433bbcb2ee5b80aa0481,

title = "Setting the hemoglobin A1c target in type 2 diabetes: a priori, a posteriori, or neither?",

abstract = "Current guidelines specify hemoglobin A1c (HbA1c) targets around or less than 7.0 %, with more (",

keywords = "A posteriori, A priori, HbA1c target, Type 2 diabetes",

author = "Dario Giugliano and Maiorino, {Maria Ida} and Giuseppe Bellastella and Michela Petrizzo and Antonio Ceriello and Stefano Genovese and Katherine Esposito",

year = "2015",

month = sep,

day = "25",

doi = "10.1007/s12020-015-0549-2",

language = "English",

volume = "50",

pages = "56--60",

journal = "Endocrine",

issn = "1355-008X",

publisher = "Humana Press Inc.",

number = "1",

}

TY - JOUR

T1 - Setting the hemoglobin A1c target in type 2 diabetes

T2 - a priori, a posteriori, or neither?

AU - Giugliano, Dario

AU - Maiorino, Maria Ida

AU - Bellastella, Giuseppe

AU - Petrizzo, Michela

AU - Ceriello, Antonio

AU - Genovese, Stefano

AU - Esposito, Katherine

PY - 2015/9/25

Y1 - 2015/9/25

N2 - Current guidelines specify hemoglobin A1c (HbA1c) targets around or less than 7.0 %, with more (

AB - Current guidelines specify hemoglobin A1c (HbA1c) targets around or less than 7.0 %, with more (

KW - A posteriori

KW - A priori

KW - HbA1c target

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84940438627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940438627&partnerID=8YFLogxK

U2 - 10.1007/s12020-015-0549-2

DO - 10.1007/s12020-015-0549-2

M3 - Article

C2 - 25672778

AN - SCOPUS:84940438627

VL - 50

SP - 56

EP - 60

JO - Endocrine

JF - Endocrine

SN - 1355-008X

IS - 1

ER -

Setting the hemoglobin A1c target in type 2 diabetes: a priori, a posteriori, or neither?

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this